High-dose Carboplatin and Etoposide for Salvage Chemotherapy of Germ Cell Tumours

By Dearnaley D.P.   Lampe H.   Price A.   Mehta J.   Powles R.   Nicholls J.   Horwich A.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 717-723

Elsevier

Access to resources Recommend Favorite

High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study

By Namouni F.   Doz F.   Tanguy M.L.   Quintana E.   Michon J.   Pacquement H.   Bouffet   Gentet J.C.   Plantaz D.   Lutz P.   Vannier J.P.   Validire P.   Neuenschwander   Desjardins L.   Zucker J.M.  

European Journal of Cancer, Vol. 33, Iss. 14, 1997-12 ,pp. : 2368-2375

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent

By Schroeder Patricia   Hofland Kenneth   Jensen Peter   Sehested Maxwell   Langer Seppo   Hasinoff Brian  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 91-93

Springer Publishing Company

Access to resources Recommend Favorite

Paclitaxel-containing High-dose Chemotherapy in High-risk Breast Cancer Patients

By Greinix Hildegard T.   Linkesch Werner   Seifert Manfred   Kubista Ernst   Czerwenka Klaus   Elahi Fariborz   Zielinski Christoph   Hoecker Paul   Steger Günther   Schulenburg Axel   Neumeister Geralt   Rabitsch Werner   Jakesz Raimund   Kalhs Peter  

Acta Oncologica, Vol. 39, Iss. 1, 2000-04 ,pp. : 47-52

Informa Healthcare

Access to resources Recommend Favorite

EVE/cyclosporin (etoposide, vincristine, epirubicin with high-dose cyclosporin)-chemotherapy selected for multidrug resistance modulation

By Davidson A.   Dick G.   Pritchard-Jones K.   Pinkerton R.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2422-2427

Elsevier

Access to resources Recommend Favorite